ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Avicanna Inc

Avicanna Inc (AVCN)

0,34
0,01
( 3,03% )
Aktualisiert: 20:40:34

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,34
Gebot
0,34
Fragen
0,345
Volumen
287.326
0,315 Tagesbereich 0,345
0,20 52-Wochen-Bereich 0,60
Marktkapitalisierung
Handelsende
0,33
Handelsbeginn
0,335
Letzte Trade
10500
@
0.34
Letzter Handelszeitpunkt
20:40:34
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
130.528
Ausgegebene Aktien
74.953.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,92
Gewinn pro Aktie (EPS)
-0,12
Erlöse
16,79M
Nettogewinn
-8,74M

Über Avicanna Inc

Sektor
Medicinal Chems,botanicl Pds
Branche
Medicinal Chems,botanicl Pds
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
Avicanna Inc is listed in the Medicinal Chems,botanicl Pds sector of the Toronto Börse with ticker AVCN. The last closing price for Avicanna was $0,33. Over the last year, Avicanna shares have traded in a share price range of $ 0,20 to $ 0,60.

Avicanna currently has 74.953.000 shares in issue. The market capitalisation of Avicanna is $24,73 million. Avicanna has a price to earnings ratio (PE ratio) of -2.92.

AVCN Neueste Nachrichten

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca  

TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Avicanna Announces Repayment of Debentures

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES...

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

USPTO issues Patent No. US 20230025693A1 (“Patent”) that covers Avicanna’s deep penetrating topicalcannabinoid composition and methods for treating musculoskeletal inflammation and pain TORONTO...

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing...

Avicanna Reports Q2 2024

Q2 2024 revenue of $6.1 million an increase of 85% over Q2 2023Completion of two real world evidence trials on Epidermolysis Bullosa and Musculoskeletal Pain TORONTO, Aug. 14, 2024 (GLOBE...

Avicanna Announces Changes of Auditors

TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing...

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all Avicanna products TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Avicanna...

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.045-11.68831168830.3850.4150.3153402970.37876157CS
4000.340.4150.3151982270.36443608CS
12-0.15-30.6122448980.490.50.291305280.3695788CS
26-0.095-21.83908045980.4350.550.21486370.34555035CS
52-0.16-320.50.60.21155070.37915571CS
156-0.45-56.96202531650.790.920.16905140.36618327CS
260-3.16-90.28571428573.54.140.16737320.68244721CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
XLYAuxly Cannabis Group Inc
$ 0,04
(14,29%)
152,62k
ESMEuro Sun Mining Inc
$ 0,05
(11,11%)
21,5k
HLSHLS Therapeutics Inc
$ 3,94
(9,44%)
5,1k
ANRGAnaergia Inc
$ 0,71
(9,23%)
217,26k
EEnterprise Group Inc
$ 2,32
(8,92%)
458,76k
BNGBengal Energy Ltd
$ 0,015
(-25,00%)
338k
GLOGlobal Atomic Corporation
$ 1,08
(-22,86%)
7,14M
APLIAppili Therapeutics Inc
$ 0,025
(-16,67%)
2k
NCFNorthcliff Resources Ltd
$ 0,025
(-16,67%)
100k
MINExcelsior Mining Corp
$ 0,15
(-14,29%)
12,5k
GLOGlobal Atomic Corporation
$ 1,08
(-22,86%)
7,14M
TDToronto Dominion Bank
$ 86,33
(-0,69%)
6,72M
BTEBaytex Energy Corp
$ 4,38
(-4,37%)
4,43M
TVETamarack Valley Energy Ltd
$ 4,13
(-2,59%)
3,34M
CVECenovus Energy Inc
$ 24,04
(-3,84%)
2,96M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock